Site search
2816 results for '' found
Evaluation of the RibFix™ Advantage Rib Fixation System for Surgical Repair of Rib Fractures (Trial Not Registered)
Evaluation of the RibFix™ Advantage Rib Fixation System for Surgical Repair of Rib Fractures (Trial Not Registered)
/research/clinical-trials/find-clinical-trials/evaluation-of-the-ribfix-advantage-rib-fixation-system-for-surgical-repair-of-rib-fractures-trial-not-registered
Re-EValuating the Inhibition of Stress Erosions and prophylaxis against gastrointestinal bleeding in the critically ill (REVISE) trial (NCT03374800)
Re-EValuating the Inhibition of Stress Erosions and prophylaxis against gastrointestinal bleeding in the critically ill (REVISE) trial (NCT03374800)
/research/clinical-trials/find-clinical-trials/re-evaluating-the-inhibition-of-stress-erosions-and-prophylaxis-against-gastrointestinal-bleeding-in-the-critically-ill-revise-trial-nct03374800
Unravelling the reversibility of pulmonary vascular disease in HFpEF, aortic stenosis and CTEPH after intervention: the REVERS-PVD study (Trial Not Registered)
Unravelling the reversibility of pulmonary vascular disease in HFpEF, aortic stenosis and CTEPH after intervention: the REVERS-PVD study (Trial Not Registered)
/research/clinical-trials/find-clinical-trials/unravelling-the-reversibility-of-pulmonary-vascular-disease-in-hfpef-aortic-stenosis-and-cteph-after-intervention-the-revers-pvd-study-trial-not-registered
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-Week Study Evaluating the Safety and Efficacy of Simufilam 100 mg Tablets in Subjects with Mild-to-moderate Alzheimer’s
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-Week Study Evaluating the Safety and Efficacy of Simufilam 100 mg Tablets in Subjects with Mild-to-moderate Alzheimer’s
/research/clinical-trials/find-clinical-trials/a-phase-3-randomized-double-blind-placebo-controlled-parallel-group-52-week-study-evaluating-the-safety-and-efficacy-of-simufilam-100-mg-tablets-in-subjects-with-mild-to-moderate-alzheimers
Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved EF Heart Failure (RESPONDER-HF) (NCT05425459)
Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved EF Heart Failure (RESPONDER-HF) (NCT05425459)
/research/clinical-trials/find-clinical-trials/re-evaluation-of-the-corvia-atrial-shunt-device-in-a-precision-medicine-trial-to-determine-efficacy-in-mildly-reduced-or-preserved-ef-heart-failure-responder-hf-nct05425459
RESpiratory pathogen Point-Of-Care Testing in Emergency Departments (ACTRN12625000123448)
RESpiratory pathogen Point-Of-Care Testing in Emergency Departments (ACTRN12625000123448)
/research/clinical-trials/find-clinical-trials/respiratory-pathogen-point-of-care-testing-in-emergency-departments-actrn12625000123448
A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects with Cystic Fibrosis and Chronic Pseudomon
A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects with Cystic Fibrosis and Chronic Pseudomon
/research/clinical-trials/find-clinical-trials/a-double-blind-active-controlled-multiple-ascending-dose-phase-1b-study-of-aerosolized-rsp-1502-delivered-via-the-pari-lc-plus-nebulizer-in-subjects-with-cystic-fibrosis-and-chronic-pseudomon
A multicenter, randomized, double-blind, chronic-dosing, parallel-group, placebo-controlled phase 3 study to evaluate the efficacy and safety of bendralizumab 100mg in patietns with moderate to v
A multicenter, randomized, double-blind, chronic-dosing, parallel-group, placebo-controlled phase 3 study to evaluate the efficacy and safety of bendralizumab 100mg in patietns with moderate to v
/research/clinical-trials/find-clinical-trials/a-multicenter-randomized-double-blind-chronic-dosing-parallel-group-placebo-controlled-phase-3-study-to-evaluate-the-efficacy-and-safety-of-bendralizumab-100mg-in-patietns-with-moderate-to-v
Randomized,Embedded,Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) (NCT02735707)
Randomized,Embedded,Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) (NCT02735707)
/research/clinical-trials/find-clinical-trials/randomizedembeddedmultifactorial-adaptive-platform-trial-for-community-acquired-pneumonia-remap-cap-nct02735707
A prospective, double-blinded, randomised study comparing 16g automated full-core and side-notch biopsy needles for percutaneous renal biopsies in renal transplant patients (Trial Not Registered)
A prospective, double-blinded, randomised study comparing 16g automated full-core and side-notch biopsy needles for percutaneous renal biopsies in renal transplant patients (Trial Not Registered)
/research/clinical-trials/find-clinical-trials/a-prospective-double-blinded-randomised-study-comparing-16g-automated-full-core-and-side-notch-biopsy-needles-for-percutaneous-renal-biopsies-in-renal-transplant-patients-trial-not-registered